Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2015

01-11-2015 | Clinical Study

Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis

Authors: Wenxi Yu, Lina Tang, Feng Lin, Yang Yao, Zan Shen

Published in: Journal of Neuro-Oncology | Issue 2/2015

Login to get access

Abstract

Controversy exists in the accuracy of Tokuhashi score (TS) system in predicting survival of patients with vertebral metastasis, including vertebral metastases from primary lung cancer. To calculate the accuracy of the TS in predicting survival of lung cancer patients with vertebral metastasis and investigate which subgroup’s survival is suitable for TS to predict, we conduct this retrospective study. From January 2008 to December 2013, 151 patients with vertebral metastases from primary lung cancer in our institute were included. The data were censored at December 2014. Patients were classified according to TS. The actual and predicted survivals were compared to calculate the accuracy rate. Spearman’s correlation analysis was conducted to explore the relation between overall survival and TS. Cox regression was carried out to investigate potential factors affecting prognosis. Only 8.6 % (13 patients) actually followed the survivorship pattern as predicted by the TS. Spearman’s correlation analysis demonstrated that actual overall survival correlated significantly with the TS. Cox model indicated that status of visceral metastases (i.e., none, involved with lung, involved with extrapulmonary organ) and response to first-time systemic therapy (effective or not) are associated significantly with overall survival. For patients with visceral metastases and progression to first-time systemic therapy simultaneously, predicted survival by TS and actual survival matched well. TS could only predict survival accurately in those with visceral metastases and disease progression to first-time systemic therapy simultaneously. Thus, it may not be a reliable tool to predict survival in lung cancer patients with vertebral metastasis. Status of visceral metastases and response to first-time systemic therapy should be added into TS system to increase validity and accuracy.
Literature
1.
go back to reference Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249sCrossRefPubMed Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249sCrossRefPubMed
2.
go back to reference Coello MC, Luketich JD, Litle VR, Godfrey TE (2004) Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer 5:214–225CrossRefPubMed Coello MC, Luketich JD, Litle VR, Godfrey TE (2004) Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer 5:214–225CrossRefPubMed
3.
go back to reference Al Husaini HMD, Wheatley-Price PMM, Clemons MMF et al (2009) Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol 4:251–259CrossRefPubMed Al Husaini HMD, Wheatley-Price PMM, Clemons MMF et al (2009) Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol 4:251–259CrossRefPubMed
4.
go back to reference Bae HM, Lee SH, Kim TM et al (2012) Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer 77:572–577CrossRefPubMed Bae HM, Lee SH, Kim TM et al (2012) Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer 77:572–577CrossRefPubMed
5.
go back to reference Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s–6249sCrossRefPubMed Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s–6249sCrossRefPubMed
7.
go back to reference Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3(1):74–85CrossRefPubMed Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3(1):74–85CrossRefPubMed
8.
go back to reference Sze WM, Shelley MD, Held I et al (2003) Palliation of metastatic bone pain: single fraction versus multi-fraction radiotherapy—a systemic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352CrossRef Sze WM, Shelley MD, Held I et al (2003) Palliation of metastatic bone pain: single fraction versus multi-fraction radiotherapy—a systemic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352CrossRef
9.
go back to reference Singh K, Samartzis D, Vaccaro AR et al (2006) Current concepts in the management of metastatic spinal disease. The role of minimallyinvasive approaches. J Bone Joint Surg Br 88(4):434–442CrossRefPubMed Singh K, Samartzis D, Vaccaro AR et al (2006) Current concepts in the management of metastatic spinal disease. The role of minimallyinvasive approaches. J Bone Joint Surg Br 88(4):434–442CrossRefPubMed
10.
go back to reference Jónsson B, Jónsson H Jr, Karlström G et al (1994) Surgery of cervical spine metastases: a retrospective study. Eur Spine J 3:76–83CrossRefPubMed Jónsson B, Jónsson H Jr, Karlström G et al (1994) Surgery of cervical spine metastases: a retrospective study. Eur Spine J 3:76–83CrossRefPubMed
11.
go back to reference Riegel T, Schilling T, Sitter H et al (2002) Analysis of factors affecting the prognosis of vertebral metastases. Zentralbl Neurochir 63(19):2–6CrossRefPubMed Riegel T, Schilling T, Sitter H et al (2002) Analysis of factors affecting the prognosis of vertebral metastases. Zentralbl Neurochir 63(19):2–6CrossRefPubMed
12.
go back to reference Hosono N, Ueda T, Tamura D et al (2005) Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop Relat Res 436:196–201CrossRefPubMed Hosono N, Ueda T, Tamura D et al (2005) Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop Relat Res 436:196–201CrossRefPubMed
13.
go back to reference Jansson KA, Bauer HCF (2006) Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbal spinal metastases. Eur Spine J 15:196–202PubMedCentralCrossRefPubMed Jansson KA, Bauer HCF (2006) Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbal spinal metastases. Eur Spine J 15:196–202PubMedCentralCrossRefPubMed
14.
go back to reference Schaser KD, Melcher I, Mittlmeier T et al (2007) Surgical management of vertebral column metastatic disease. Unfallchirurg 110(2):137–159CrossRefPubMed Schaser KD, Melcher I, Mittlmeier T et al (2007) Surgical management of vertebral column metastatic disease. Unfallchirurg 110(2):137–159CrossRefPubMed
15.
go back to reference Tokuhashi Y, Yasumitsu A, Umezawa N (2009) Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine 34:69–73CrossRefPubMed Tokuhashi Y, Yasumitsu A, Umezawa N (2009) Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine 34:69–73CrossRefPubMed
16.
go back to reference Pointillart V, Vital J, Salmi R, Diallo A, Quan GM (2011) Survival prognostic factors and clinical outcomes in patients with spinal metastases. J Cancer Res Clin Oncol 137:849–856CrossRefPubMed Pointillart V, Vital J, Salmi R, Diallo A, Quan GM (2011) Survival prognostic factors and clinical outcomes in patients with spinal metastases. J Cancer Res Clin Oncol 137:849–856CrossRefPubMed
17.
go back to reference Choi D, Crockard A, Bunger C et al (2010) Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 19:215–222PubMedCentralCrossRefPubMed Choi D, Crockard A, Bunger C et al (2010) Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 19:215–222PubMedCentralCrossRefPubMed
18.
go back to reference Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 30:2186–2191CrossRef Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 30:2186–2191CrossRef
19.
go back to reference Ulmar B, Huch K, Naumann U et al (2007) Evaluation of the Tokuhashi prognosis score and its modifications in 217 patients with vertebral metastases. Eur J Surg Oncol 33:914–919CrossRefPubMed Ulmar B, Huch K, Naumann U et al (2007) Evaluation of the Tokuhashi prognosis score and its modifications in 217 patients with vertebral metastases. Eur J Surg Oncol 33:914–919CrossRefPubMed
20.
go back to reference Ulmar B, Richter M, Cakir B et al (2005) The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine (Phila Pa 1976) 30:2222–2226CrossRef Ulmar B, Richter M, Cakir B et al (2005) The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine (Phila Pa 1976) 30:2222–2226CrossRef
21.
go back to reference Yamashita T, Siemionow KB, Mroz TE et al (2011) A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine (Phila Pa 1976) 36:910–917CrossRef Yamashita T, Siemionow KB, Mroz TE et al (2011) A prospective analysis of prognostic factors in patients with spinal metastases: use of the revised Tokuhashi score. Spine (Phila Pa 1976) 36:910–917CrossRef
22.
go back to reference Putz C, Wiedenhofer B, Gerner HJ et al (2008) Tokuhashi prognosis score: an important tool in prediction of the neurological outcome in metastatic spinal cord compression: a retrospective clinical study. Spine (Phila Pa 1976) 33:2669–2674CrossRef Putz C, Wiedenhofer B, Gerner HJ et al (2008) Tokuhashi prognosis score: an important tool in prediction of the neurological outcome in metastatic spinal cord compression: a retrospective clinical study. Spine (Phila Pa 1976) 33:2669–2674CrossRef
23.
go back to reference Quraishi NA, Manoharan SR, Arealis G et al (2013) Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 22(Suppl 1):21–26PubMedCentralCrossRef Quraishi NA, Manoharan SR, Arealis G et al (2013) Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 22(Suppl 1):21–26PubMedCentralCrossRef
24.
go back to reference Gakhar H, Swamy GN, Bommireddy R et al (2013) A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer. Eur Spine J 22:565–568PubMedCentralCrossRefPubMed Gakhar H, Swamy GN, Bommireddy R et al (2013) A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer. Eur Spine J 22:565–568PubMedCentralCrossRefPubMed
25.
go back to reference Papastefanou S, Alpantaki K, Akra G, Katonis P (2012) Predictive value of Tokuhashi and Tomita scores in patients with metastatic spine disease. Acta Orthop Traumatol Turc. 46(1):50–56CrossRefPubMed Papastefanou S, Alpantaki K, Akra G, Katonis P (2012) Predictive value of Tokuhashi and Tomita scores in patients with metastatic spine disease. Acta Orthop Traumatol Turc. 46(1):50–56CrossRefPubMed
26.
go back to reference Kim J, Lee SH, Park SJ, Chung SS, Kim ES, Eoh W, Lee CS (2014) Analysis of the predictive role and new proposal for surgical strategies based on the modified Tomita and Tokuhashi scoring systems for spinal metastasis. World J Surg Oncol 12:245PubMedCentralCrossRefPubMed Kim J, Lee SH, Park SJ, Chung SS, Kim ES, Eoh W, Lee CS (2014) Analysis of the predictive role and new proposal for surgical strategies based on the modified Tomita and Tokuhashi scoring systems for spinal metastasis. World J Surg Oncol 12:245PubMedCentralCrossRefPubMed
27.
go back to reference Aoude A (2014) Amiot LP.A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis. Can J Surg 57(3):188–193PubMedCentralCrossRefPubMed Aoude A (2014) Amiot LP.A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis. Can J Surg 57(3):188–193PubMedCentralCrossRefPubMed
28.
go back to reference Hernandez-Fernandez A, Vélez R, Lersundi-Artamendi A, Pellisé F (2012) External validity of the Tokuhashi score in patients with vertebral metastasis. J Cancer Res Clin Oncol 138(9):1493–1500CrossRefPubMed Hernandez-Fernandez A, Vélez R, Lersundi-Artamendi A, Pellisé F (2012) External validity of the Tokuhashi score in patients with vertebral metastasis. J Cancer Res Clin Oncol 138(9):1493–1500CrossRefPubMed
29.
go back to reference Hessler C, Vettorazzi E, Madert J, Bokemeyer C, Panse J (2011) Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine (Phila Pa 1976) 36(12):983–989CrossRef Hessler C, Vettorazzi E, Madert J, Bokemeyer C, Panse J (2011) Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine (Phila Pa 1976) 36(12):983–989CrossRef
30.
go back to reference Park S, Lee C, Chung S, Lee K (2014) How accurately can Tokuhashi score system predict the survival in the current practice for spinal metastases? Prospective analysis of consecutive 145 patients between 2007 and 2013. J Spinal Disord Tech [Epub ahead of print] Park S, Lee C, Chung S, Lee K (2014) How accurately can Tokuhashi score system predict the survival in the current practice for spinal metastases? Prospective analysis of consecutive 145 patients between 2007 and 2013. J Spinal Disord Tech [Epub ahead of print]
31.
go back to reference Gangi A, Sabharwal T, Irani FG, Buy X, Morales JP, Adam A (2006) Quality assurance guidelines for percutaneous vertebroplasty. Cardiovasc Intervent Radiol 29:173–178CrossRefPubMed Gangi A, Sabharwal T, Irani FG, Buy X, Morales JP, Adam A (2006) Quality assurance guidelines for percutaneous vertebroplasty. Cardiovasc Intervent Radiol 29:173–178CrossRefPubMed
32.
go back to reference McGraw JK, Cardella J, Barr JD et al (2003) Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol 14:827–831CrossRefPubMed McGraw JK, Cardella J, Barr JD et al (2003) Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol 14:827–831CrossRefPubMed
33.
go back to reference Wang Z, Zhen Y, Wu C, Li H, Yang Y, Shen Z, Zhao H, Yao Y (2012) CT fluoroscopy-guided percutaneous osteoplasty for the treatment of osteolytic lung cancer bone metastases to the spine and pelvis. J Vasc Interv Radiol 23(9):1135–1142CrossRefPubMed Wang Z, Zhen Y, Wu C, Li H, Yang Y, Shen Z, Zhao H, Yao Y (2012) CT fluoroscopy-guided percutaneous osteoplasty for the treatment of osteolytic lung cancer bone metastases to the spine and pelvis. J Vasc Interv Radiol 23(9):1135–1142CrossRefPubMed
34.
go back to reference Carnio S, Novello S, Mele T, Levra MG, Scagliotti GV (2014) Extending survival of stage IV non-small cell lung cancer. Semin Oncol 41(1):69–92CrossRefPubMed Carnio S, Novello S, Mele T, Levra MG, Scagliotti GV (2014) Extending survival of stage IV non-small cell lung cancer. Semin Oncol 41(1):69–92CrossRefPubMed
35.
go back to reference Faria SL (2014) Role of radiotherapy in metastatic non-small cell lung cancer. Front Oncol 13(4):22 Faria SL (2014) Role of radiotherapy in metastatic non-small cell lung cancer. Front Oncol 13(4):22
36.
37.
go back to reference Jeremic B, Casas F, Wang L, Perin B (2010) Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC. Front Radiat Ther Oncol 42:180–186CrossRefPubMed Jeremic B, Casas F, Wang L, Perin B (2010) Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC. Front Radiat Ther Oncol 42:180–186CrossRefPubMed
38.
go back to reference Wolf M, Tebbe S, Fink T (2004) First-line chemotherapy in metastatic small-cell lung cancer (SCLC). Lung Cancer 45(Suppl 2):S223–S234CrossRefPubMed Wolf M, Tebbe S, Fink T (2004) First-line chemotherapy in metastatic small-cell lung cancer (SCLC). Lung Cancer 45(Suppl 2):S223–S234CrossRefPubMed
39.
go back to reference Kim YH, Mishima M (2011) Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev 37(2):143–150CrossRefPubMed Kim YH, Mishima M (2011) Second-line chemotherapy for small-cell lung cancer (SCLC). Cancer Treat Rev 37(2):143–150CrossRefPubMed
40.
go back to reference Noda K, Nishiwaki Y, Kawahara M et al (2002) Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell-lung cancer. N Engl J Med 346(2):85–91CrossRefPubMed Noda K, Nishiwaki Y, Kawahara M et al (2002) Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell-lung cancer. N Engl J Med 346(2):85–91CrossRefPubMed
Metadata
Title
Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis
Authors
Wenxi Yu
Lina Tang
Feng Lin
Yang Yao
Zan Shen
Publication date
01-11-2015
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2015
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1934-7

Other articles of this Issue 2/2015

Journal of Neuro-Oncology 2/2015 Go to the issue